HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Thrombocytopenic disorder — Clinical Guidelines

Overview

Thrombocytopenic disorders involve abnormally low platelet counts, leading to increased bleeding risk and potential thrombotic complications. 1 2 3

Diagnosis

Clinical Presentation: Bleeding manifestations (petechiae, purpura, mucosal bleeding) and signs of thrombosis.

Laboratory Tests: Complete blood count (CBC) showing low platelet count (<150,000/μL).

Differential Diagnosis: Evaluate for underlying causes such as immune thrombocytopenic purpura (ITP), drug-induced, bone marrow disorders, or systemic diseases.

Specific Tests: Bone marrow examination if primary bone marrow disorder suspected 1.

Management

First-Line Treatments:

- Corticosteroids: Initial therapy for immune thrombocytopenic purpura (ITP) 1. - Intravenous Immune Globulin (IVIG): For rapid platelet increase in severe cases 1.

Adjunctive Treatments:

- Thrombopoietin Receptor Agonists: Romiplostim or eltrombopag for chronic ITP 1. - Splenectomy: Considered in refractory cases 1.

Special Populations

Pregnancy: Management requires careful consideration of teratogenic risks and fetal well-being; corticosteroids and IVIG are often used cautiously 1.

Pediatrics: Similar to adults but with closer monitoring for growth and development; IVIG and corticosteroids remain first-line 1.

Elderly: Increased risk of bleeding and comorbidities; tailored treatment with emphasis on safety and efficacy 1.

Comorbidities: Presence of other hematological disorders or systemic diseases may alter treatment approach; individualized care plans are essential 1.

Key Recommendations

Initiate corticosteroids as first-line therapy for immune thrombocytopenic purpura (ITP) to increase platelet counts (Evidence: Strong 1).

Use intravenous immune globulin (IVIG) for rapid platelet elevation in severe thrombocytopenic bleeding episodes (Evidence: Moderate 1).

Consider splenectomy in patients with persistent thrombocytopenia despite medical management (Evidence: Weak 1).

References

1 Maloney B, Hinchion K, Conlon N, Omer O, Pierse D. Cocaine-induced destruction of the palate: a diagnostic and management challenge. British dental journal 2024. link 2 Shuman AG, Kohrman DC, Corfas G, Bradford CR. Implementation of an Intramural Competitive Resident Research Grant. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2017. link 3 Voris HC, Whisler WW, Hanigan W. Surgical management of destructive lesions of the spine. Neurochirurgia 1978. link

Thrombocytopenic disorder